Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | May 05, 2023 09:06am

Gainers

  • Nanobiotix (NASDAQ:NBTX) stock increased by 125.6% to $4.58 during Friday's pre-market session. The company's market cap stands at $161.3 million.
  • Star Equity Hldgs (NASDAQ:STRR) stock moved upwards by 24.63% to $0.86. The company's market cap stands at $13.0 million.
  • Aditxt (NASDAQ:ADTX) stock rose 19.94% to $0.79. The market value of their outstanding shares is at $4.0 million.
  • Telesis Bio (NASDAQ:TBIO) shares moved upwards by 17.81% to $3.24. The company's market cap stands at $96.0 million.
  • Fulgent Genetics (NASDAQ:FLGT) stock increased by 15.7% to $33.0. The company's market cap stands at $979.8 million. The company's, Q1 earnings came out today.
  • Owens & Minor (NYSE:OMI) stock moved upwards by 14.98% to $15.58. The company's market cap stands at $1.1 billion. As per the press release, Q1 earnings came out today.

Losers

  • Soligenix (NASDAQ:SNGX) stock fell 34.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $4.3 million.
  • Biolase (NASDAQ:BIOL) stock decreased by 14.6% to $0.23. The market value of their outstanding shares is at $6.0 million.
  • Celyad Oncology (NASDAQ:CYAD) shares fell 11.74% to $0.6. The market value of their outstanding shares is at $13.5 million.
  • Akili (NASDAQ:AKLI) stock declined by 10.07% to $1.34. The market value of their outstanding shares is at $104.6 million.
  • SI-BONE (NASDAQ:SIBN) stock declined by 9.04% to $22.25. The market value of their outstanding shares is at $782.8 million. As per the press release, Q1 earnings came out 4 days ago.
  • Can Fite Biofarma (AMEX:CANF) shares declined by 8.5% to $1.94. The market value of their outstanding shares is at $7.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ADTX AKLI BIOL CANF CYAD FLGT NBTX OMI SIBN SNGX STRR TBIO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist